Literature DB >> 20816585

Polycystic ovary syndrome and autoimmunity.

Jana Petríková1, Ivica Lazúrová, Shoenfeld Yehuda.   

Abstract

Polycystic ovary syndrome (PCOS) is characterized by laboratory and/or clinical features consisting of hyperandrogenism with chronic anovulation and is currently one of the most common endocrinopathies in women of fertile age. PCOS is associated with a variety of endocrine and metabolic disturbances. It was demonstrated that the prevalence of autoimmune thyroiditis is high among these patients. Recent studies reveal a higher incidence of autoantibodies such as anti-histone, anti-dsDNA presented in systemic autoimmune disease, however their clinical significance is still unknown. According to results of current research the syndrome could be possibly associated with some autoimmune diseases. Further studies are required to determine the role of organ-specific and non-specific autoantibodies in patients with PCOS. Copyright (c) 2010. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816585     DOI: 10.1016/j.ejim.2010.06.008

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  20 in total

1.  Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome.

Authors:  Giovanna Muscogiuri; Stefano Palomba; Mario Caggiano; Domenico Tafuri; Annamaria Colao; Francesco Orio
Journal:  Endocrine       Date:  2015-10-03       Impact factor: 3.633

2.  Antithyroid Peroxidase Antibodies in Women with Polycystic Ovary Syndrome.

Authors:  Maya Menon; Vijayalakshmi Ramachandran
Journal:  J Obstet Gynaecol India       Date:  2016-06-08

3.  Peripheral Blood Inflammatory-Immune Cells as a Predictor of Infertility in Women with Polycystic Ovary Syndrome.

Authors:  ShuQiong He; XiaoDan Mao; HuiFang Lei; BinHua Dong; DanHua Guo; BeiHong Zheng; PengMing Sun
Journal:  J Inflamm Res       Date:  2020-08-18

4.  GnRH receptor-activating autoantibodies in polycystic ovary syndrome: identification of functional epitopes and development of epitope mimetic inhibitors.

Authors:  Hongliang Li; Yankai Guo; Jielin Deng; Hariprasad Gali; Elizabeth A Weedin; Heather R Burks; LaTasha B Craig; Xichun Yu
Journal:  Endocrine       Date:  2021-11-22       Impact factor: 3.633

5.  Serum Levels of Anti-histone and Anti-double-Strand DNA Antibodies Before and After Laparoscopic Ovarian Drilling in Women with Polycystic Ovarian Syndrome.

Authors:  Dehaghani Alamtaj Samsami; Parisa Razmjoei; Mohammad Ebrahim Parsanezhad
Journal:  J Obstet Gynaecol India       Date:  2013-09-25

6.  The relationship between thyroiditis and polycystic ovary syndrome: a meta-analysis.

Authors:  Danfeng Du; Xuelian Li
Journal:  Int J Clin Exp Med       Date:  2013-10-25

Review 7.  Polycystic ovary syndrome: current status and future perspective.

Authors:  Erin K Barthelmess; Rajesh K Naz
Journal:  Front Biosci (Elite Ed)       Date:  2014-01-01

8.  Increased testosterone and proinflammatory cytokines in patients with polycystic ovary syndrome correlate with elevated GnRH receptor autoantibody activity assessed by a fluorescence resonance energy transfer-based bioassay.

Authors:  Hongliang Li; Yankai Guo; Jielin Deng; Hayley Fischer; Elizabeth A Weedin; Heather R Burks; LaTasha B Craig; Xichun Yu
Journal:  Endocrine       Date:  2021-05-20       Impact factor: 3.925

9.  Bilateral Spontaneous Perirenal Hemorrhage due to Initial Presentation of Polyarteritis Nodosa.

Authors:  Hyung-Il Choi; Yang-Gyun Kim; Se-Yun Kim; Da Wun Jeong; Ki-Pyo Kim; Kyung-Hwan Jeong; Sang-Ho Lee; Ju-Young Moon
Journal:  Case Rep Med       Date:  2015-09-01

10.  Anti-Nuclear Antibodies in Patients with Polycystic Ovary Syndrome before and after Laparoscopic Electrocauterization.

Authors:  Alamtaj Samsami Dehaghani; Nazanin Karimaghaei; Mohammad Ebrahim Parsanezhad; Mahyar Malekzadeh; Mohammad Mehrazmay; Nasrollah Erfani
Journal:  Iran J Med Sci       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.